miR-146aC>G,miR-149T>C基因多态性与缺血性脑卒中易感性的研究

目的:探讨中国汉族人群中miR-146aCG,miR-149TC基因多态性与缺血性脑卒中易感性的关系。方法:利用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)的方法检测196例缺血性脑卒中患者和205例健康对照中miR-146aCG,miR-149TC的基因型,统计学方法比较两组间基因型及等位基因分布差异。结果:miR-146aCG位点各基因型在病例组和对照组分布无明显差异,但等位基因G会增加缺血性脑卒中的患病风险;miR-149TC位点各基因型在病例组和对照组分布无明显差异。在分层分析中,miR-146aCG会增加女性和非高血压患者缺血性脑卒中的患病风险,miR-149TC会增加非高血压患者缺血性脑卒中的患病风险。结论:miR-146aG等位基因,miR-149C等位基因与汉族人群缺血性脑卒中易感性有一定的相关性。     

miR-146aC〉G,miR-149T〉C基因多态性与缺血性脑卒中易感性的研究

目的：探讨中国汉族人群中miR-146aC〉G,miR-149T〉C基因多态性与缺血性脑卒中易感性的关系。方法：利用聚合酶链式反应-限制性片段长度多态性（PCR-RFLP）的方法检测196例缺血性脑卒中患者和205例健康对照中miR-146aC〉G,miR-149T〉C的基因型,统计学方法比较两组间基因型及等位基因分布差异。结果：miR-146aC〉G位点各基因型在病例组和对照组分布无明显差异,但等位基因G会增加缺血性脑卒中的患病风险;miR-149T〉C位点各基因型在病例组和对照组分布无明显差异。在分层分析中,miR-146aC〉G会增加女性和非高血压患者缺血性脑卒中的患病风险,miR-149T〉C会增加非高血压患者缺血性脑卒中的患病风险。结论：miR-146aG等位基因,miR-149C等位基因与汉族人群缺血性脑卒中易感性有一定的相关性。     

NEDD4L基因变异体与内蒙古地区蒙古族人群中高血压的相关分析

目的：探讨内蒙古地区蒙古族人群中NEDD4L基因多态性位点rs4149601（G／A）突变与高血压的相关性。方法：应用病例对照方法研究包头地区蒙古族高血压病个体308例及蒙古族血压正常个体454例。检测所有个体舒张压,收缩压。使用TaqManPCR技术进行rs4149601多态基因分型。结果：rs4149601多态基因型及等位基因分布在GG基因型、GA基因型、AA等位基因的频率在高血压组及对照组分别为54．7％,92．8％;11．4％及56．2％;71．4％,7．9％。rs4149601多态基因型及等位基因分布与对照组差异有显著性。应用多元logistic回归分析对性别、年龄进行校正后发现rs4149601多态基因与高血压病患病风险相关。结论：上皮细胞钠通道亚单位基因多态性（rs4149601）同内蒙古地区蒙古族人群高血压病发病有关。     

MTHFR基因多态性与动脉粥样硬化性脑梗塞的关系

采用ＰＣＲ－ ＲＦＬＰ技术,检测了６２ 例动脉粥样硬化性脑梗塞患者和７９ 名对照者的Ｃ６７７Ｔ 突变的基因型。结果发现, ＭＴＨＦＲ基因Ｃ６７７Ｔ 突变型等位基因（Ｖ）频率在实验组和对照组中,有显著性差异（χ２＝ ４．４１,Ｐ＜ ０．０５）;三种基因型频率在两组人群中均无显著性差异。基因型频率的相对风险分析,ＡＶ基因型比ＡＡ 基因型患脑梗塞风险高１．７６ 倍;ＶＶ 基因型比ＡＡ 基因型患脑梗塞风险高３．２５ 倍。结果表明, ＭＴＨＦＲ 基因Ｃ６７７Ｔ 突变型等位基因与动脉粥样硬化性脑梗塞有一定的关联,突变基因型增加了动脉粥样硬化脑梗塞的发病风险。     

NEDD4L基因变异体与内蒙古地区蒙古族人群中高血压 的相关分析

目的：探讨内蒙古地区蒙古族人群中NEDD4L基因多态性位点rs4149601(G/A)突变与高血压的相关性。方法：应用病例对 照方法研究包头地区蒙古族高血压病个体308 例及蒙古族血压正常个体454 例。检测所有个体舒张压,收缩压。使用TaqMan PCR技术进行rs4149601 多态基因分型。结果：rs4149601 多态基因型及等位基因分布在GG 基因型、GA 基因型、AA 等位基因的 频率在高血压组及对照组分别为54.7%,92.8%;11.4%及56.2%;71.4%,7.9%。rs4149601 多态基因型及等位基因分布与对照组差 异有显著性。应用多元logistic 回归分析对性别、年龄进行校正后发现rs4149601 多态基因与高血压病患病风险相关。结论：上皮 细胞钠通道亚单位基因多态性(rs4149601)同内蒙古地区蒙古族人群高血压病发病有关。     

麦洼牦牛和九龙牦牛FSHβ基因的PCR-SSCP分析

运用一对特异性引物对麦洼牦牛、九龙牦牛的FSHβ基因的5’端侧翼区进行了扩增,应用PCR-SSCP方法对其进行了多态性分析。结果表明:在麦洼牦牛的FSHβ基因的5’端侧翼区有AA型、AB型和BB型三种基因型,九龙牦牛的FSHβ基因的5’端侧翼区只检测到了AA型、AB型两种基因型。在两种牦牛品系中,AA基因型频率最高,A等位基因频率均明显高于B等位基因频率。麦洼牦牛和九龙牦牛群体中多态信息含量分别为0.3431、0.1411,麦洼牦牛多态性能高,遗传变异大。     

MTHFR基因多态性与动脉粥样硬化性脑梗塞的关系

采用PCR-RFLP技术,检测了62例动脉粥样硬化性脑梗塞患者和79名对照者的C677T突变的基因型。结果发现, MTHFR基因C677T 突变型等位基因(V)频率在实验组和对照组中,有显著性差异(χ2＝4.41,P<0.05);三种基因型频率在两组人群中均无显著性差异。基因型频率的相对风险分析,AV基因型比AA基因型患脑梗塞风险高1.76倍;VV基因型比AA基因型患脑梗塞风险高3.25倍。结果表明, MTHFR基因C677T突变型等位基因与动脉粥样硬化性脑梗塞有一定的关联,突变基因型增加了动脉粥样硬化脑梗塞的发病风险。 Abstract:　In order to detect the relationship between MTHFRgene C677Tpolymorphism and arteriosclerotic cerebral infarction, this study examined the genotype of 62 patients with arteriosclerotic cerebral infarction and 79 control subjects by PCR-RFLP. The result showed that there was significance difference between patients and control subjects in V allele frequency of MTHFRgene C677Tmutation (χ2＝4.41,P<0.05) and there was no difference between patients and control subjects in genotype frequency of MTHFRgene C677Tmutation. The relative risk for arteriosclerotic cerebral infaction of heterozygote (AV/AA) was 1.76 and that of homozygote (VV/AA) was 3.25. The study confirmed an association between mutated allele of the MTHFRgene C677Tand arteriosclerotic cerebral infarction, mutated genotypes increased the risk of arteriosclerotic cerebral infarction.     

胆固醇7α-羟化酶基因 A-204C单核苷酸多态性及其与血浆血脂的关联

为探讨胆固醇7α-羟化酶基因(CYP7A1)多态性与中国四川汉族人群的分布及其与冠状动脉粥样硬化性心脏病(coronary heart disease,CHD)易感性的关系,对183例CHD患者和101例对照用聚合酶链反应-限制性片段长度多态性方法(PCR-RFLP)进行CYP7A1基因A-204C基因座Eco31I酶切多态性分析。结果可见CYP7A1基因A-204C多态基因座等位基因C、A频率在CHD组和正常对照组分别为0.840、0.160和0.822、0.178,基因频率分布符合Hardy-Weiberg平衡定律。CYP7A1基因A-204C多态基因座基因型频率,等位基因A、C频率在CHD患者组和正常对照组间比较差异无显著性(P>0.05),但冠心病患者组中AA,AC,CC3种基因型之间总胆固醇(TC)的差异具有显著性(P<0.05),AA基因型患者的高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)水平较AC,CC基因型患者显著降低(P<0.05);而对照组中CC,CA基因型个体间总胆固醇(TC)水平差异有显著性(P<0.05)。中国汉族与白种人CYP7A1基因A-204C多态基因座等位基因频率比较,两者差异具有显著性(P<0.01)。提示CYP7A1基因A-204C多态基因座多态性与CHD无相关性,但与总胆固醇存在较密切的关联(P相似文献   

猪H-FABP基因PCR-SSCP分析

应用PCR-SSCP方法分析了H-FABP基因在山西白猪、马身猪、大白猪、长白猪和杜洛克猪5个猪种的多态性。结果表明:在H-FABP基因内含子1中发现了多态位点,该位点上具有两个等位基因A和B,马身猪BB基因型频率最高,B等位基因频率明显高于A等位基因频率;其余4个猪种AA基因型频率最高。序列测定的结果表明,SSCP的变异是由碱基C→T的替换造成的。     

P21WAF1基因单核苷酸多态性和东北地区HPV相关宫颈癌的关系

研究P21WAF1基因单核苷酸多态性与中国东北地区人群HPV阳性宫颈癌风险的关系.以聚合酶链反应-直接测序的方法分析了340例宫颈癌患者标本P21WAF1基因rs1801270和rs3176352多态性,比较不同基因型与宫颈癌风险的关系.rs3176352多态在宫颈癌患者中的分布和正常对照组差异不显著,与宫颈癌风险无关.rs1801270多态在宫颈癌患者中的分布和正常对照组差异显著,宫颈癌患者中C等位基因频率、CC和AC基因型频率明显高于正常对照组(P＜0.05);与携带A等位基因者比较,携带C等位基因者罹患宫颈癌的风险增加1.366 7倍(95％ CI:1.1121～1.6792).P21WAF1基因rs1801270多态C等位基因是东北地区人群宫颈癌遗传易感因素.     

Polymorphism of SG13S114T/A in the ALOX5AP Gene and the Risk for Stroke in a Large Chinese Cohort

The 5-lipoxygenase activating protein, an important regulator in the biosynthesis of proinflammatory leukotrienes, has been reported to confer risks for cardiovascular diseases and stroke. The purpose of this study is to assess whether genetic variants in the ALOX5AP encoding the 5-lipoxygenase activating protein will influence the risk for stroke in the Chinese population. A total of 1 773 patients with stroke and 1 713 controls were recruited from seven clinical centers. Polymorphisms of SG13S114T/A and SG13S89G/A in the ALOX5AP were genotyped by the polymerase chain reaction and the restriction enzyme analysis. The multivariate logistic regression model was used to exclude the influence of the conventional vascular risk factors on stroke. The frequency of SG13S114A allele in the ALOX5AP was significantly higher in male patients with thrombotic stroke (33.6%) than in controls (29.2%; P=0.014). The SG13S114AA genotype was significantly associated with a 1.62-fold risk for thrombotic stroke in men (95% confidence interval, 1.11 to 2.35; P=0.012). The SG13S89G/A variant was not associated with stroke or its subtypes. Haplotype analysis showed no significant differences between stroke patients and controls. The present study suggested that a common genetic variant SG13S114T/A in the ALOX5AP gene is associated with an increased risk for atherothrombotic stroke in Chinese males, and racial differences in allele and genotype frequencies may account partially for the different association findings between populations.     

Polymorphic variants of ALOX5AP gene and the risk of acute stroke development in the Russian population

A protein capable of activating 5-lipoxygenase (ALOX5AP) is considered a presumable risk factor of acute stroke development. Polymorphic variants of the ALOX5AP gene were examined. Two ALOX5AP gene polymorphisms (SG13S114 (rs10507391) and SG13S32 (rs9551963)), which previously had shown association with the risk of ischemic stroke in other populations, were studied. These single nucleotide polymorphisms were analyzed using a sample of acute stroke patients (N = 1320) and a control sample (N = 467). No statistically significant associations were found between acute stroke and the ALOX5AP gene polymorphisms examined.     

Genetic polymorphisms of <Emphasis Type="Italic">T-1131C APOA5</Emphasis> and <Emphasis Type="Italic">ALOX5AP SG13S114</Emphasis> with the susceptibility of ischaemic stroke in Morocco

Ischaemic stroke is a multifactorial disease. Genetic polymorphisms involved in lipid, inflammatory and thrombotic metabolisms play an important role in the development of ischaemic stroke. The present study aimed to assess the relationship between T1131C APOA5 and SG13S114 ALOX5AP polymorphisms and the risk of ischemic stroke in 175 cases and 201 controls. Genotyping was performed by high resolution melting and polymerase chain reaction restriction fragment length polymorphism methods. In the case of T-1131C APOA5, a modest risk of ischaemic stroke was noticed with CC (OR: 2.86; 95% CI = 1.24–6.58; Pc = 0.039) and C allele (OR: 1.54; 95% CI = 1.01–2.33; Pc = 0.014). For SG13S114ALOX5AP, a significant association was observed among subjects with TT (OR: 2.57; 95% CI =1.49–4.83; Pc = 0.009) and T allele (OR: 1.59; 95% CI = 1.16–2.19; Pc = 0.008). According to the risk factors of ischaemic stroke, a positive correlation was observed only between SG13S114 variant of ALOX5AP gene and hypertension (Pc = 0.026). Despite lower sample size, T-1131C APOA5 and SG13S114 variants could be considered an independent genetic risk factor of ischaemic stroke in Moroccan population.     

Correlation Between Cerebral Infarction and ALOX5AP Gene Expression

Linkage/linkage-disequilibrium analysis studies, based on positional information and gene function, indicated that ALOX5AP gene was an independent risk factor of cerebral infarction in humans; however, this needs to be verified among different populations. Herein, we verified whether ALOX5AP was a risk factor of cerebral infarction in the Chinese Han population. For this purpose, 547 cerebral infarction patients were enrolled as the case group; the control group comprised 794 healthy, age-matched individuals unrelated to case group and had no history of cerebral infarction/transient ischemic attack. Regarding single-nucleotide polymorphism (SNP) selection and ALOX5AP genotyping, we selected four SNP loci (SG13S25, SG13S114, SG13S89, and SG13S32) and determined allelic frequencies. Genotyping of SG13S114 and SG13S32 adopted a method of combining real-time quantitative PCR and allele-specific PCR. A linkage-disequilibrium analysis of ALOX5AP was also performed. We found that the allelic frequencies of SG13S25 and SG13S89 were below 5 % and those of SG13S114 and SG13S32 were above 5 %. We did not find any differences between the case and control groups regarding allele, allele types, and haplotype gene frequencies of two SNP loci. The results indicate that the two genetic polymorphisms of ALOX5AP, SG13S114 and SG13S32, are not associated with cerebral infarction in Chinese Han population.     

The arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene SG13S114 polymorphism and ischemic stroke in Chinese population: A meta-analysis

Previous studies have indicated that the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene SG13S114 polymorphism is associated with risk of ischemic stroke (IS), but the results remain inconclusive even in Chinese population. A meta-analysis of 10 case-control studies was conducted on the relationship between ALOX5AP SG13S114 polymorphism and susceptibility to IS in Chinese population published domestically and abroad from September 2007 to December 2012. Data were extracted by two authors and pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Meta-analysis results showed that the significant association between SG13S114 variant and IS was found under the allelic (OR = 0.87, 95% CI: 0.80–0.96, P = 0.004), dominant (OR = 0.75, 95% CI: 0.62–0.92, P = 0.005), and recessive (OR = 0.89, 95% CI: 0.82–0.97, P = 0.005) genetic models in Chinese population. In subgroup meta-analysis, SG13S114 variant and atherothrombotic stroke, rather than lacunar stroke, showed the significant association under the allelic (OR = 0.86, 95% CI: 0.80–0.92, P < 0.0001), dominant (OR = 0.72, 95% CI: 0.57–0.91, P = 0.006), and recessive (OR = 0.86, 95% CI: 0.78–0.95, P = 0.002) models. ALOX5AP SG13S114 polymorphism is associated with susceptibility to IS in Chinese population.     

Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population

Cardiovascular diseases, including myocardial infarction (MI) and stroke, most often occur on the background of atherosclerosis, a condition attributed to the interactions between multiple genetic and environmental risk factors. We recently reported a linkage and association study of MI and stroke that yielded a genetic variant, HapA, in the gene encoding 5-lipoxygenase-activating protein (ALOX5AP), that associates with both diseases in Iceland. We also described another ALOX5AP variant, HapB, that associates with MI in England. To further assess the contribution of the ALOX5AP variants to cardiovascular diseases in a population outside Iceland, we genotyped seven single-nucleotide polymorphisms that define both HapA and HapB from 450 patients with ischemic stroke and 710 controls from Aberdeenshire, Scotland. The Icelandic at-risk haplotype, HapA, had significantly greater frequency in Scottish patients than in controls. The carrier frequency in patients and controls was 33.4% and 26.4%, respectively, which resulted in a relative risk of 1.36, under the assumption of a multiplicative model (P=.007). We did not detect association between HapB and ischemic stroke in the Scottish cohort. However, we observed that HapB was overrepresented in male patients. This replication of haplotype association with stroke in a population outside Iceland further supports a role for ALOX5AP in cardiovascular diseases.     

Polymorphic variants of <Emphasis Type="Italic">ALOX</Emphasis>5<Emphasis Type="Italic">AP</Emphasis> gene and the risk of acute stroke development in the Russian population

The role of variants of the gene encoding arachidonate 5-lipoxygenase-activating protein (ALOX5AP) as possible susceptibility factors for acute stroke were examinated. Two ALOX5AP gene polymorphisms (SG13S114 (rs10507391) and SG13S32 (rs9551963)), which previously had shown association with the risk of ischemic stroke in other populations, were studied. These single nucleotide polymorphisms were analyzed using a sample of acute stroke patients (N = 1320) and a control sample (N = 467). No statistically significant associations were found between acute stroke and the ALOX5AP gene polymorphisms examined.     

Promoter methylation and functional variants in arachidonate 5-lipoxygenase and forkhead box protein O1 genes associated with coronary artery disease

Coronary artery disease (CAD) is a multifactorial chronic inflammatory disease, which is the most common form of heart disease. This is one of the main causes of death in the United States. Inflammation is one of the key drivers of atherosclerotic plaque development. Forkhead box protein O1 (FOXO1s) family and 5-lipoxygenase make an important contribution to atherosclerosis. The aim of this study was to investigate the methylation pattern and polymorphism analysis of FOXO1 and arachidonate 5-lipoxygenase (ALOX5) promoter genes. We studied 50 patients with CAD and 50 age- and sex-matched healthy controls by high resolution melt technique. Overall, we found significant differences between patients and controls in terms of the promoter methylation of ALOX5 (P > 0.05). But there was no significant difference in FOXO1 promoter methylation between patient and controls. Single nucleotide polymorphisms genotyping of rs12762303 and rs2297627, in ALOX5 and FOXO1 genes were demonstrated a significant correlation between mutant allele and the risk of CAD, respectively. Furthermore, there were significant associations between CT + CC genotype and ALOX5 expression. Our findings demonstrated functional effects of single nucleotide polymorphisms (SNPs) and DNA methylation in ALOX5 on mentioned genes expression and they resulted in CAD progression.     

Association of ALOX5AP with ischemic stroke: a population-based case-control study

Arachidonate 5-lipoxygenase activating protein (ALOX5AP) has been reported to demonstrate linkage and association with ischemic stroke and myocardial infarction. However, replication studies have been conflicting and to date, a significant proportion of blacks have not been studied. We prospectively recruited cases of ischemic stroke from all 16 hospitals in the Greater Cincinnati/Northern Kentucky region and demographically matched them to stroke-free population-based controls. Single nucleotide polymorphisms (SNPs) were selected based on association with ischemic stroke in prior studies. Allelic, genotypic and haplotypic association testing was performed using HAPLOVIEW. Multiple logistic regression was used to control for the presence of traditional risk factors including hypertension, diabetes, hypercholesterolemia and smoking. A total of 357 cases and 482 controls were genotyped. The SNPs, rs9579646 and rs4769874 were found to be significantly associated at both allelic (P = 0.019 and P < 10⁻⁴, respectively) and genotypic level with ischemic stroke among whites after correction for multiple testing. Haplotype association was identified with ischemic stroke as well as ischemic stroke subtypes among whites. Although an overall haplotype association with ischemic stroke was identified among blacks no evidence of association among individual haplotypes, alleles or genotypes were observed. Allele frequencies for the SNPs examined were markedly different among whites and blacks. In conclusion, we report significant association of variants of ALOX5AP with ischemic stroke and ischemic stroke subtypes among whites. No significant association was identified among blacks.     

A Promoter polymorphism (rs17222919, -1316T/G) of ALOX5AP is associated with intracerebral hemorrhage in Korean population

To investigate whether single nucleotide polymorphisms (SNPs) of eicosanoid biosynthesis genes are associated with intracerebral hemorrhage (ICH) and ischemic stroke (IS), seven SNPs in the coding or promoter regions were selected: ALOX12 (rs434473, Asn322Ser), ALOX5 (rs2228064, Thr90Thr), ALOX5AP (rs17222919, -1316T/G), PTGES (rs7872802, -404A/G), PTGIS (rs5628, Leu256Leu), PTGS1 (rs3842788, Gln41Gln) and PTGS2 (rs5275, 3'UTR). A total of 398 control subjects and 196 stroke patients (79 ICH and 117 IS) were genotyped by direct sequencing. The rs17222919 SNP was associated with ICH in codominant 1 (P=0.008), dominant (P=0.003) and log-additive (P=0.004) models. Allele frequencies of rs17222919 were different between ICH and controls (P=0.007). However, the seven tested SNPs were not associated with clinical phenotypes (NIHSS, MBI and CRPS) in ICH and IS. These results suggest that the promoter SNP rs17222919 of ALOX5AP may be associated with the development of ICH in Korean population.